SS31 10mg Canada

Technical Specifications

Compound Name: SS31 (also known as Elamipretide in clinical literature)
Quantity: 10mg per vial
Format: Lyophilized peptide powder
Peptide Length: 4 amino acids (tetrapeptide)
Sequence: D-Arg-dimethylTyr-Lys-Phe-NH₂
Molecular Weight: Approximately 639.8 g/mol
Purity Standard: ≥98% (HPLC, batch dependent)
Research Classification: Investigational peptide – laboratory research use only

SS31 10mg Canada is supplied as a lyophilized synthetic tetrapeptide intended exclusively for laboratory and analytical applications. Each vial contains 10 milligrams of the peptide prepared under controlled handling and quality verification standards appropriate for research material distribution.

This product is classified as an investigational research compound and is not authorized for therapeutic, diagnostic, or consumer use in Canada.

Research Overview

SS31 is a synthetic mitochondria-targeted peptide that has been studied extensively in experimental models of cellular energy regulation and oxidative stress. It belongs to a class of small peptides designed to localize within the inner mitochondrial membrane selectively.

Research on SS31 10mg Canada generally focuses on mitochondrial bioenergetics, cardiolipin interactions, and modulation of reactive oxygen species in laboratory settings. The peptide’s ability to accumulate in mitochondria without requiring a membrane potential has made it a subject of interest in cellular metabolism research.

The scientific literature describes SS31 in preclinical and early-stage clinical studies that examine mitochondrial function under stress conditions. Experimental models often include cell cultures and animal systems used to evaluate mitochondrial membrane integrity, ATP production, and oxidative balance.

SS31 10mg Canada is supplied strictly for research purposes. All references to biological processes reflect investigational findings from laboratory and clinical studies and do not imply approved medical application.

Mechanism Overview

SS31 is a cell-permeable tetrapeptide that selectively associates with cardiolipin, a phospholipid located in the inner mitochondrial membrane. In laboratory models, this interaction has been shown to stabilize mitochondrial cristae structure and support electron transport chain efficiency.

By binding to cardiolipin, SS31 has been studied for its ability to influence reactive oxygen species production and mitochondrial membrane potential stability in experimental systems. Researchers evaluating SS31 10mg Canada often measure parameters such as ATP synthesis rates, mitochondrial respiration efficiency, and oxidative stress markers.

Unlike many peptides that act through classical receptor-mediated pathways, SS31 primarily acts through mitochondrial membrane-interaction mechanisms in laboratory models. Mechanistic descriptions remain confined to preclinical and investigational findings and are presented for educational purposes only.

Clinical Development Context

SS31 has progressed through various stages of clinical investigation under regulated development programmes. Early-phase clinical trials have examined pharmacokinetics, safety parameters, and mitochondrial-related biomarkers in human subjects under controlled conditions.

Despite its presence in clinical research pipelines, SS31 10mg, supplied in research-grade format, is categorized as an investigational laboratory compound. It is distinct from any authorized pharmaceutical formulation and is not represented as an approved medication in Canada.

Scientific publications describe ongoing interest in mitochondria-targeted therapeutics, and SS31 is frequently cited in research exploring mitochondrial dysfunction models.

Regulatory Status in Canada

Health Canada does not approve SS31 as a prescription medication, natural health product, or over-the-counter drug in peptide research format.

SS31 10mg Canada is classified as an investigational research peptide and is supplied exclusively for laboratory and analytical use. It is not intended for human or veterinary administration.

Handling, storage, and research involving SS31 10mg Canada must comply with applicable Canadian federal and provincial regulations governing chemical and biological research materials. Laboratories and research institutions are responsible for ensuring regulatory compliance.

Molecular and Structural Notes

SS31 is a synthetic tetrapeptide with the sequence D-Arg-dimethylTyr-Lys-Phe-NH₂. The presence of aromatic and cationic residues contributes to its affinity for cardiolipin-rich mitochondrial membranes in experimental models.

The peptide’s relatively small molecular weight of approximately 639.8 g/mol allows efficient cellular uptake in laboratory systems. Structural modifications, including the use of D-amino acids and amidation, enhance stability against in vitro enzymatic degradation.

SS31 10mg Canada is typically characterized using analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry to confirm identity and purity before distribution.

The lyophilized format supports peptide stability during storage when maintained under appropriate laboratory conditions.

Frequently Asked Questions

What is SS31 10mg Canada studied for in research?
SS31 10mg Canada is being studied in laboratory settings to investigate mitochondrial bioenergetics and oxidative stress pathways.

Is SS31 approved for medical use in Canada?
No. Health Canada does not authorize it for therapeutic or consumer use in research-grade format.

What type of peptide is SS31?
It is a synthetic, mitochondria-targeted tetrapeptide studied in cellular energy research.

Does SS31 10mg Canada contain additives?
Unless specified in the batch documentation, the vial contains only the lyophilized peptide compound.

Can SS31 10mg Canada be used outside research facilities?
No. It is supplied strictly for controlled laboratory and analytical research purposes.

Educational Disclaimer

SS31 10mg Canada is an investigational research peptide supplied solely for laboratory and analytical use. Health Canada does not approve it as a medication, therapeutic agent, or consumer product.

Information provided on this page is educational in nature and based on publicly available scientific literature describing investigational research contexts. No medical, diagnostic, or therapeutic claims are made.

Study and handling of SS31 10mg Canada should occur only within properly equipped research facilities and in accordance with applicable Canadian regulations and institutional guidelines.